Pengli Bu
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Mitochondrial Function and Pathology 3
- Retinoids in leukemia and cellular processes 2
-
- Reproductive System and Pregnancy 3
- Immune Cell Function and Interaction 2
- Co-authors
- Aleš Vančura (6 shared papers)Ivana Vancurova (5 shared papers)Madhura Bhagwat (3 shared papers)Yu‐Jui Yvonne Wan (3 shared papers)Xingguo Cheng (9 shared papers)Guoli Dai (2 shared papers)Lin He (1 shared paper)Abu T.M. Serajuddin (3 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)Toxicology (3 papers)Biology of Reproduction (3 papers)European Journal of Pharmaceutical Sciences (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Pengli Bu
29 papers receiving 933 citations
Peers
Comparison fields: 5 of 100
- Pharmaceutical Science 65
- Cancer Research 136
- Molecular Biology 500
- Oncology 188
- Pharmacology 58
Countries citing papers authored by Pengli Bu
This map shows the geographic impact of Pengli Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengli Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengli Bu more than expected).
Fields of papers citing papers by Pengli Bu
This network shows the impact of papers produced by Pengli Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengli Bu. The network helps show where Pengli Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pengli Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 206 | |
| 2 | 2004 | 96 | |
| 3 | 2007 | 86 | |
| 4 | 2017 | 58 | |
| 5 | 2016 | 58 | |
| 6 | 2018 | 48 | |
| 7 | 2016 | 46 | |
| 8 | 2018 | 41 | |
| 9 | 2017 | 36 | |
| 10 | 2016 | 31 | |
| 11 | 2009 | 30 | |
| 12 | 2012 | 27 | |
| 13 | 2010 | 26 | |
| 14 | 2020 | 22 | |
| 15 | 2016 | 19 | |
| 16 | 2007 | 17 | |
| 17 | 2019 | 17 | |
| 18 | 2017 | 16 | |
| 19 | 2024 | 12 | |
| 20 | 2017 | 12 |
About Pengli Bu
Pengli Bu is a scholar working on Molecular Biology, Immunology, Surgery, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 946 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (3 papers), Drug Solubulity and Delivery Systems (3 papers), Pancreatic function and diabetes (3 papers), Birth, Development, and Health (3 papers), Reproductive System and Pregnancy (3 papers), Per- and polyfluoroalkyl substances research (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Pharmaceutical Science (65 citations), Cancer Research (136 citations), Molecular Biology (500 citations), Oncology (188 citations) and Pharmacology (58 citations). Pengli Bu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Aleš Vančura, Ivana Vancurova, Madhura Bhagwat, Yu‐Jui Yvonne Wan, Xingguo Cheng, Guoli Dai, Lin He, Abu T.M. Serajuddin, Tiantian Zhang and Mari Enoksson. Their work appears in journals such as Journal of Biological Chemistry, Toxicology, Biology of Reproduction, European Journal of Pharmaceutical Sciences and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.